Search Results - "Jesteadt, Eric"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia by Nishimura, Yoshiaki, Donau, Olivia K, Dias, Joana, Ferrando-Martinez, Sara, Jesteadt, Eric, Sadjadpour, Reza, Gautam, Rajeev, Buckler-White, Alicia, Geleziunas, Romas, Koup, Richard A, Nussenzweig, Michel C, Martin, Malcolm A

    Published in The Journal of experimental medicine (04-01-2021)
    “…We report that combination bNAb immunotherapy initiated on day 3 post-infection (PI) maintained durable CD8+ T cell-mediated suppression of SHIVAD8 viremia and…”
    Get full text
    Journal Article
  2. 2

    Interleukin-18 Is Critical for Mucosa-Associated Invariant T Cell Gamma Interferon Responses to Francisella Species In Vitro but Not In Vivo by Jesteadt, Eric, Zhang, Irma, Yu, Huifeng, Meierovics, Anda, Chua Yankelevich, Wei-Jen, Cowley, Siobhan

    Published in Infection and immunity (01-05-2018)
    “…Mucosa-associated invariant T (MAIT) cells are a subset of innate T cells that express a semi-invariant Vα chain paired with limited Vβ chains. MAIT cells are…”
    Get full text
    Journal Article
  3. 3

    Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent D-peptide HIV entry inhibitor by Nishimura, Yoshiaki, Francis, J. Nicholas, Donau, Olivia K., Jesteadt, Eric, Sadjadpour, Reza, Smith, Amanda R., Seaman, Michael S., Welch, Brett D., Martin, Malcolm A., Kay, Michael S.

    “…Cholesterol-PIE12-trimer (CPT31) is a potent D-peptide HIV entry inhibitor that targets the highly conserved gp41 N-peptide pocket region. CPT31 exhibited…”
    Get full text
    Journal Article